Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Cana…
$39.17+3.95%
报价 2026-11-06
市值
$3.79B
EV
$4.98B
PE (TTM)
–
预期 PE
–
52 周区间距高点 -44.8%
$33.49$70.96
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Biotechnology| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| XENEXenon Pharmaceuticals Inc. | $3.79B | +4.0% | – | 0% | – | – | – | |
| RLAYRelay Therapeutics, Inc. | $4.08B | +9.4% | -14.8% | 89.7% | – | – | – | |
| LQDALiquidia Corporation | $3.97B | -0.2% | +371.0% | 92.5% | 30.2x | 23.0x | 70.1x | |
| ABCLAbCellera Biologics Inc. | $3.85B | +6.7% | – | 75% | – | – | – | |
| AMLXAmylyx Pharmaceuticals, Inc. | $3.7B | +6.8% | -99.9% | 0% | – | – | – | |
| ACADACADIA Pharmaceuticals Inc. | $3.66B | -0.0% | +14.8% | 91.7% | 9.1x | 26.3x | 34.6x | |
| IOVAIovance Biotherapeutics, Inc. | $3.64B | +3.9% | +41.2% | 48.4% | – | – | – | |
| TNGXTango Therapeutics, Inc. | $3.63B | +3.0% | -90.3% | 98.3% | – | – | – | |
| ELVNEnliven Therapeutics, Inc. | $3.62B | +10.4% | – | 0% | – | – | – | |
| 同行中位数 | – | – | -0.0% | 82.3% | 19.6x | 24.6x | 52.3x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。